Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$44.3K
9.91K shares
What this filing means
CARTER TODD ALFRED plans to sell 9.91K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $44.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/20/2025ACC: 0001959173-25-001201
Officer· Chief Scientific Officer
Since Feb 2026
9.91K
Shares to sell
$44.3K
Approx. market value
3.31K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/14/2025
3.31KTotal acquired3.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Restricted Stock Vesting Compensation | 3.31K | — |
| Total | 3.31K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.41K
Market value
$24.1K
2/11/2025
—Completed
Units to sell
1.19K
Market value
$6.1K
1/14/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.31K
Market value
$14.1K
2/20/2025
Total
Units
9.91K
Value
$44.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2025 | 5.41K | $24.1K | — | Completed |
1/14/2025 | 1.19K | $6.1K | — | Completed |
| Planned — Approximate Date | ||||
2/20/2025 | 3.31K | $14.1K | NASDAQ | Planned |
| Total | 9.91K | $44.3K | ||